Watchlist Price Alert

Eledon Pharmaceuticals In... (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

2.80

0.00 (0.00%)

At close: Jun 17, 2025, 1:50 PM

Eledon Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	20.55M	4.61M	56.41M	84.83M	114.19M	8.79M	12.97M	17.23M	23.22M
Short-Term Investments	119.63M	46.49M	n/a	n/a	n/a	n/a	n/a	n/a	4.17M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	363K	186K	150K	400K	383K	639K	869K	n/a	120K
Receivables	n/a	n/a	n/a	n/a	110K	245K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	1.29M	881K	n/a	n/a	n/a
Other Current Assets	729K	90K	28K	34K	38K	54K	630K	88K	47K
Total Current Assets	143.73M	56.13M	59.52M	88.35M	115.63M	9.97M	14.28M	19M	29.54M
Property-Plant & Equipment	926K	365K	739K	768K	138K	321K	14K	25K	98K
Goodwill & Intangibles	32.39M	32.39M	32.39M	81.03M	81.03M	n/a	1.87M	1.87M	n/a
Total Long-Term Assets	33.67M	32.94M	33.27M	82.2M	81.56M	960K	2.75M	1.89M	218K
Total Assets	177.41M	89.07M	92.79M	170.55M	197.19M	10.93M	17.03M	20.89M	29.76M
Account Payables	5.83M	967K	2.2M	1.81M	1.37M	329K	689K	418K	338K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.45M
Short-Term Debt	314K	n/a	363K	369K	144K	n/a	n/a	n/a	3.45M
Other Current Liabilities	1.6M	2M	1.64M	1.15M	798K	n/a	n/a	n/a	n/a
Total Current Liabilities	11.58M	3.9M	6.47M	4.4M	2.48M	1.32M	2.53M	1.44M	2.82M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	44.87M	76.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	47.69M	77.96M	2.13M	2.15M	4.11M	144K	1.84M	1.02M	84K
Total Liabilities	59.27M	81.86M	8.61M	6.55M	6.59M	1.47M	2.53M	1.44M	2.9M
Total Debt	954K	383K	746K	769K	144K	324K	n/a	n/a	3.45M
Common Stock	60K	24K	14K	14K	15K	13K	9K	7K	23K
Retained Earnings	-355.59M	-319.4M	-202.87M	-114.9M	-80.39M	-57.58M	-41.57M	-27.51M	-169.4M
Comprehensive Income	26K	n/a	0.00	n/a	0.00	-0.00	n/a	n/a	-1K
Shareholders Equity	118.14M	7.21M	84.18M	164M	190.6M	9.46M	14.49M	19.45M	26.86M
Total Investments	119.63M	46.49M	n/a	n/a	n/a	n/a	n/a	n/a	4.17M